Centoxin
Davidson, J.; Tarlow, M.
British Journal of Hospital Medicine 49(2): 121-122
1993
ISSN/ISBN: 0007-1064 PMID: 8435673 Document Number: 412672
Centoxin is one of a new group of immunotherapeutic agents manufactured from 'humanized' antibodies produced using monoclonal antibody technology. It is indicated in the management of patients with Gram-negative septicaemia; its introduction represents a new approach to treatment in these patients (Luce, 1987).